These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 25864811)

  • 1. Comparative assessment of neutrophil gelatinase-associated lipocalin (NGAL) and cystatin C as early biomarkers for early detection of renal failure in patients with hypertension.
    Gharishvandi F; Kazerouni F; Ghanei E; Rahimipour A; Nasiri M
    Iran Biomed J; 2015; 19(2):76-81. PubMed ID: 25864811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma neutrophil-gelatinase-associated lipocalin and cystatin C could early diagnose contrast-induced acute kidney injury in patients with renal insufficiency undergoing an elective percutaneous coronary intervention.
    Liu XL; Wang ZJ; Yang Q; Yu M; Shen H; Nie B; Han HY; Gao F; Zhou YJ
    Chin Med J (Engl); 2012 Mar; 125(6):1051-6. PubMed ID: 22613530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Neutrophil Gelatinase-Associated Lipocalin Versus B-Type Natriuretic Peptide and Cystatin C to Predict Early Acute Kidney Injury and Outcome in Patients With Acute Heart Failure.
    Palazzuoli A; Ruocco G; Pellegrini M; De Gori C; Del Castillo G; Franci B; Nuti R; Ronco C
    Am J Cardiol; 2015 Jul; 116(1):104-11. PubMed ID: 25943992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in hypertensive and normotensive patients with coronary artery disease.
    Malyszko J; Bachorzewska-Gajewska H; Malyszko JS; Pawlak K; Dobrzycki S
    Nephrology (Carlton); 2008 Apr; 13(2):153-6. PubMed ID: 18275504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implications of the changes in serum neutrophil gelatinase-associated lipocalin and cystatin C in patients with chronic kidney disease.
    Shen SJ; Hu ZX; Li QH; Wang SM; Song CJ; Wu DD; He JL; Guan JC; Shan JP
    Nephrology (Carlton); 2014 Mar; 19(3):129-35. PubMed ID: 24397346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of biochemical markers in the early post-burn period for predicting acute kidney injury and mortality in patients with major burn injury: comparison of serum creatinine, serum cystatin-C, plasma and urine neutrophil gelatinase-associated lipocalin.
    Yang HT; Yim H; Cho YS; Kym D; Hur J; Kim JH; Chun W; Kim HS
    Crit Care; 2014 Jul; 18(4):R151. PubMed ID: 25023056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophil gelatinase-associated lipocalin is a new and sensitive marker of kidney function in chronic kidney disease patients and renal allograft recipients.
    Malyszko J; Malyszko JS; Bachorzewska-Gajewska H; Poniatowski B; Dobrzycki S; Mysliwiec M
    Transplant Proc; 2009; 41(1):158-61. PubMed ID: 19249502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutrophil Gelatinase--Associated Lipocalin and Cystatin C Are Sensitive Markers of Renal Injury in Patients With Multiple Myeloma.
    Papassotiriou GP; Kastritis E; Gkotzamanidou M; Christoulas D; Eleutherakis-Papaiakovou E; Migkou M; Gavriatopoulou M; Roussou M; Margeli A; Papassotiriou I; Dimopoulos MA; Terpos E
    Clin Lymphoma Myeloma Leuk; 2016 Jan; 16(1):29-35. PubMed ID: 26632077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum Neutrophil Gelatinase-Associated Lipocalin and Cystatin C for Assessing Recovery of Graft Function in Patients Undergoing Living-Donor Kidney Transplantation.
    Liu Y; Li HX; Ying ZW; Guo JJ; Cao CY; Jia W; Yang HR
    Clin Lab; 2016; 62(1-2):155-63. PubMed ID: 27012045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of kidney function in diabetic patients. Is there a role for new biomarkers NGAL, cystatin C and KIM-1?
    Matys U; Bachorzewska-Gajewska H; Malyszko J; Dobrzycki S
    Adv Med Sci; 2013; 58(2):353-61. PubMed ID: 24384771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kidney function assessed by eGFR, cystatin C and NGAL (neutrophil gelatinase-associated lipocalin) in relation to age in heart allograft recipients.
    Przybylowski P; Malyszko J; Malyszko J
    Med Sci Monit; 2010 Sep; 16(9):CR440-4. PubMed ID: 20802417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma neutrophil gelatinase-associated lipocalin (NGAL) correlations with cystatin C, serum creatinine, and glomerular filtration rate in patients after heart and lung transplantation.
    Szewczyk M; Wielkoszyński T; Zakliczyński M; Zembala M
    Transplant Proc; 2009 Oct; 41(8):3242-3. PubMed ID: 19857721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in children with chronic kidney disease.
    Mitsnefes MM; Kathman TS; Mishra J; Kartal J; Khoury PR; Nickolas TL; Barasch J; Devarajan P
    Pediatr Nephrol; 2007 Jan; 22(1):101-8. PubMed ID: 17072653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutrophil gelatinase-associated lipocalin in the diagnosis of type 1 cardio-renal syndrome in the general ward.
    Alvelos M; Pimentel R; Pinho E; Gomes A; Lourenço P; Teles MJ; Almeida P; Guimarães JT; Bettencourt P
    Clin J Am Soc Nephrol; 2011 Mar; 6(3):476-81. PubMed ID: 21115620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of plasma neutrophil gelatinase-associated lipocalin for mortality in patients with heart failure.
    van Deursen VM; Damman K; Voors AA; van der Wal MH; Jaarsma T; van Veldhuisen DJ; Hillege HL
    Circ Heart Fail; 2014 Jan; 7(1):35-42. PubMed ID: 24347663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel and conventional serum biomarkers predicting acute kidney injury in adult cardiac surgery--a prospective cohort study.
    Haase-Fielitz A; Bellomo R; Devarajan P; Story D; Matalanis G; Dragun D; Haase M
    Crit Care Med; 2009 Feb; 37(2):553-60. PubMed ID: 19114878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophil gelatinase-associated lipocalin and cystatin C for the prediction of clinical events in patients with advanced heart failure and after ventricular assist device placement.
    Pronschinske KB; Qiu S; Wu C; Kato TS; Khawaja T; Takayama H; Naka Y; Templeton DL; George I; Farr MA; Mancini DM; Schulze PC
    J Heart Lung Transplant; 2014 Dec; 33(12):1215-22. PubMed ID: 25049066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum cystatin C and serum and urine NGAL in the kidney function assessment of patients with MGUS.
    Stelmach-Goldys A; Czarkowska-Paczek B; Wyczalkowska-Tomasik A; Paczek L
    Eur J Haematol; 2015 Feb; 94(2):162-8. PubMed ID: 25046079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum neutrophil gelatinase-associated lipocalin and cystatin C are early biomarkers of contrast-induced nephropathy after coronary angiography in patients with chronic kidney disease.
    Alharazy SM; Kong N; Saidin R; Gafor AH; Maskon O; Mohd M; Zakaria SZ
    Angiology; 2014 May; 65(5):436-42. PubMed ID: 23580616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of atorvastatin on NGAL and cystatin C in chronic kidney disease: a post hoc analysis of the LORD trial.
    Fassett RG; Robertson IK; Ball MJ; Geraghty DP; Cardinal JW; Coombes JS
    Nephrol Dial Transplant; 2012 Jan; 27(1):182-9. PubMed ID: 21543653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.